JD-5037 ≥98%
促销价¥{{model.attbuying.price}}
市场价¥0.00
累计销量0 累计评价0 人评论
-
{{item.title}}
| 包装规格: | 5mg 10mg 25mg 50mg 100mg in glass bottle |
| 溶解性: | 溶于DMSO(≥100 mg/mL) |
| 产品描述: | 基本信息 产品编号: J10046 产品名称: JD-5037 CAS: 1392116-14-1 储存条件 粉末 -20℃ 四年 分子式: C27H27Cl2N5O3S 溶于液体 -80℃ 6个月 分子量: 572.51 -20℃ 1个月 化学名: (2S)-2-[[[(4S)-5-(4-chlorophenyl)-4-phenyl-3,4-dihydropyrazol-2-yl]-[(4-chlorophenyl)sulfonylamino]methylidene]amino]-3-methylbutanamide Solubility (25°C): 体外: DMSO 100mg/mL (174.66mM) Ethanol 2mg/mL (3.49mM) Water Insoluble 体内(现配现用): <1mg/ml表示微溶或不溶。 普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 制备储备液 浓度 溶液体积 质量 1mg 5mg 10mg 1mM 1.7467mL 8.7335mL 17.4669mL 5mM 0.3493mL 1.7467mL 3.4934mL 10mM 0.1747mL 0.8733mL 1.7467mL 50mM 0.0349mL 0.1747mL 0.3493mL 生物活性 产品描述 一种 CB1R 有效拮抗剂,IC50 值为 1.5nM。 靶点 CB1 1.5nM (IC50) 体内研究 JD5037 (3mg/kg/d,i.p.) induces equal reductions in body weight, attenuates the HFD-induced hyperglycemia,and reduces the HFD-induced hepatic injury and steatosis in obese Magel2-null mice.JD5037 (3mg/kg/day,p.o.) significantly reduces the size of tumors and abrogates the tumor in DEN-treated mice.JD5037 attenuates the AEA levels in HCC samples from mice. 推荐实验方法(仅供参考) 动物实验: Mice:JD-5037 is formulated in vehicle (V;1% Tween80,4% DMSO,95% Saline).Obese mice are treated chronically (28 d) with vehicle (V;1% Tween80,4% DMSO,95% Saline),JD5037,or SLV319 at a dose of 3mg/kg,i.p. Body weight and food intake are monitored daily.Mice are euthanized by cervical dislocation under anesthesia;the brain,hypothalamus,liver,and combined fat pads are removed,weighed,and snap-frozen,and trunk blood is collected for determining the endocrine and biochemical parameters. |
| 保存条件: | -20℃ |
-
蜀牛玻璃三角瓶
¥85.00 销量:16
-
15mL锥底离心管,袋装灭菌,橙色盖
¥636.00 销量:12
-
UFC5030BK 超滤管[0.5ml 30KD]
¥52.00 销量:10
-
UFC5010BK 超滤管[0.5ml 10KD]
¥52.00 销量:10
-
20×TBST缓冲液
¥130.00 销量:10
-
10mL移液管,易撕型全塑包装
¥456.00 销量:10
-
¥158.00
通用型 DNA 纯化回收试剂盒 -
¥158.00
质粒快速小提试剂盒 -
¥828.00
100mm TC细胞培养皿,袋装灭菌

